Dr. Andree K. Bates outlines what oncology marketers need to do to ensure commercial success
Angelo DePalma explores prescription to over-the-counter (Rx to OTC) switches as a strategy for extending a product’s commercial life
Rita E. Numerof argues that pharma firms should focus more on health outcomes and less on product or device features
Dr. Andrée K. Bates outlines 3 value-based strategies to effectively defend against new market entrants
Agnitio CEO Morten Hjelmsø on how technology can help marketers to do what they do best: communicate!
Rita E. Numerof explores marketing strategies that enable organizations to move beyond simple brand position and product benefits
Why market research must reflect a strategic as opposed to tactical view of markets
The recent release of Edelman’s Health Barometer 2011, continues to demonstrate how consumers are redefining what health means to them and their expectations for greater support by key constituents in their lives, including business and government.
Networking requires us to recognise that we all have something to offer
The NIH’s Undiagnosed Diseases Program (UDP) has so far discovered two new rare diseases
How online info helps to change opinions, even among physicians
Melonie Warfel, director, Life Sciences Industry Solutions, Pegasystems, on how to foster a culture of business transformation
How I learned to love the iPad a little bit less
Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, discusses pharma’s social media opportunities and the importance of data analytics
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs
Andrew Tolve investigates the opportunities and challenges for pharma’s use of cloud computing
Phil Taylor explores how pharma’s relationship to key opinion leaders is changing - for the better
Angelo DePalma explores what it costs to bring a new drug to market—and why it matters